It is the twentieth anniversary of the new patent act in January 2025. The post-patent (P20) era is a story of resilience, determination, and charting a course that set global ambitions, a story of finding opportunity in adversity. It is a story for case studies in business schools, in international studies, in global health efforts.

A Tale of Two Truths: Severance, Up in the...

“If we look at major trends, people are living longer, on average, so there’s a rise in chronic diseases associated with aging. Meanwhile, healthcare workers are in short supply, and physicians and nurses do not have enough time for patients. Yet everyone has powerful computers in their pockets that give them access to technology, education, and information. Put all that together, and it’s the perfect moment for digital solutions to come to the market, change behavior, and enhance health outcomes at scale” - Bozidar Jovicevic, Global head of Digital Therapeutics, Sanofi

The digital revolution is the fourth industrial revolution. It changes models, processes and whole public sectors. In many reports you will find that, in terms of digitalization, pharma is just next to the public sector, as least digitalized. Pharma just started late. There are many reasons for that – it is one of the most regulated industries with lots of sensitive data involved and many ethical aspects. But the slowed down digitalization has a lot to do with some subjective reasons. Adopting digital technologies requires changing existing models which requires a different mindset – and this is difficult to achieve. Nowadays, in the situation of a global pandemic, we see that digital communication is not only necessary to be successful but it is a must in order to adapt to the New Normality.

Articles by K. Hariram, Pankaj Mehrotra, Rinkesh Shah, Gopal Kishore, Amaninder S. Dhillon, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, and Mahendra Kumar Rai

Something remarkable has happened in the Indian pharmaceutical market....

C-Suite Executive Summary India stands at a pivotal juncture in...

With over 25 years of leadership experience across commercial...

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

The July Brand Monitor by Pharmarack shows a healthy...

Something remarkable has happened in the Indian pharmaceutical market....

C-Suite Executive Summary India stands at a pivotal juncture in...

With over 25 years of leadership experience across commercial...

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

The July Brand Monitor by Pharmarack shows a healthy...

Something remarkable has happened in the Indian pharmaceutical market....

C-Suite Executive Summary India stands at a pivotal juncture in...

With over 25 years of leadership experience across commercial...

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

The July Brand Monitor by Pharmarack shows a healthy...

Something remarkable has happened in the Indian pharmaceutical market....

C-Suite Executive Summary India stands at a pivotal juncture in...

With over 25 years of leadership experience across commercial...

Executive Summary The geopolitical landscape of pharmaceutical manufacturing is shifting...

The July Brand Monitor by Pharmarack shows a healthy...